Alkermes plc (ALKS) vs Dr. Reddy's Laboratories Ltd (RDY)
- Alkermes plc ALKS 41.22 +2.79%
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
Alkermes plc and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $10.7B against $6.7B — 1.6× the size. Dr. Reddy's Laboratories Ltd trades at the lower P/E: 32.9× against 102×. Alkermes plc grew revenue faster over the last twelve months: 10.8% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs 3.97%) and the higher return on invested capital (5.89% vs 2.76%). Across the 22 metrics below, Dr. Reddy's Laboratories Ltd leads on 14 and Alkermes plc on 8.
Valuation
Profitability
| Metric | ALKS | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 84.56% | 50.00% | 53.94% |
| Operating margin | 7.03% | 10.91% | 0.00% |
| Net margin | 3.97% | 9.81% | 0.00% |
| Free cash flow margin | 13.35% | 4.05% | 0.00% |
| Return on equity | 3.85% | 8.21% | (0.40%) |
| Return on assets | 1.99% | 5.55% | (3.32%) |
| Return on invested capital | 2.76% | 5.89% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack